Hyperglycemia in HIV/AIDS

Diabetes Spectrum

Volumn 19, Issue 3, 2006, Pages 163-166

  Spollett, Geralyn R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; MEGESTROL ACETATE; METFORMIN; PENTAMIDINE ISETHIONATE; PIOGLITAZONE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ROSIGLITAZONE; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASCITES; BRAIN DISEASE; CYTOTOXICITY; DYSPNEA; GLUCOSE HOMEOSTASIS; HEART ARREST; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; JAUNDICE; MEDICAL RESEARCH; NAUSEA; PNEUMONIA; REVIEW; SIDE EFFECT; WEIGHT REDUCTION;

EID: 33749651394     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.19.3.163     Document Type: Review

References (26)

1. Hommes MJT, Romijn JA, Endert E, Schattenkerk JKME, Sauerwein HP: Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism 40:651-656, 1991
2. Mulligan K, Grunfeld C, Hellerstein M, Neese RA, Schambelan M: Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency syndrome. J Clin Endocrinol Metab 77:956-962, 1993
3. Heyligenberg R, Romijn JA, Hommes JT, Endert E, Schattenkerk JKME, Sauerwein HP: Non-insulin mediated glucose uptake in human immunodeficiency virus-infected men. Clin Sci 84:209-216, 1993
4. Hommes MJT, Romijn JA, Endert E, Sauerwein HP: Resting energy expenditure and substrate oxidation in human immunodeficiency virus-infected asymptomatic men: HIV affects host metabolism in the early stage. Am J Clin Nutr 54:311-315, 1991
5. Dube MP: Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin Infect Dis 31:1467-1475, 2000
6. Osei K, Falko JM, Nelson KP, Stephens R: Diabetogenic effect of pentamidine in vitro and in vivo in a patient with malignant insulinoma. Am J Med 77:41-46, 1984
7. Bouchard PH, Sai P, Reach G, Caubarrere I, Ganeval D, Assa R: Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 31:40-45, 1982
8. Waskin H, Stehr-Green JK, Helmick CG, Sattler ER: Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. JAMA 260:345-347, 1988
9. Henry K, Rathgaber S, Sullivan C, McCabe K: Diabetes mellitus induced by megesterol acetate in patients with AIDS and cachexia. Ann Intern Med 116:53-54, 1992
10. Kilby JM, Tabereaux PB: Severe hyperglycemia in an HIV clinic: pre-existing versus drug-associated diabetes mellitus. J Acquir Immune Defic Syndr 17:46-50, 1998
11. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA: Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA Panel. JAMA 277:1962-1969, 1997
12. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA: Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlidaemia and diabetes mellitus: a cohort study. Lancet 335:2093-2099, 1999
13. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS: Antiretroviral therapy and the prevalence and incidence of diabetes in a multicenter AIDS cohort study. Arch Intern Med 165:1179-1184, 2005
14. Martinez E, Conget I, Lozano L, Casamitjana R, Gatell JM: Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. AIDS 13:805-810, 1999
15. Walli R, Herfort O, Michl GM, Demant T, Jager H, Dieterie C, Bogner JR, Landgraf R, Goebel FD: Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 12:F167-F173, 1998
16. Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG: Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr 21:209-213, 1999
17. Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz J-M, Awwka FT, Mulligan K, Schambelan M, Grunfeld C: The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS 8:641-649, 2004
18. Lee GA, Rao M, Grunfeld C: The effects of HIV protease inhibitors on carbohydrate and lipid metabolism. Curr Infect Dis Rep 6:471-482, 2004
19. Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, Welle SL, Gerich JE: Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 52:918-925, 2003
20. Schambelan M, Benson CA, Carr A, Currier JS, Dube MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS: Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA Panel. J Acquir Immune Defic Syndr 33:257-275, 2002
21. Howard AA, Floris-Moore A, Arnsten JH, Santoro N, Fleischer N, Lo Y, Schoenbaum EK: Disorders of glucose metabolism in HIV-infected women. Clin Infect Dis 40:1492-1499, 2005
22. Beatty G, Khalili M, Abbasi F, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, Koch J: Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors. J Acquir Immune Defic Syndr 33:34-40, 2003
23. Taiwo BO: Insulin resistance, HIV infection and anti-HIV therapies. AIDS Reader 15:171-176, 2005
24. Hadigan C, Corcoran C, Syanley T, Piecuch S, Klibanski A, Grinspoon S: Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. J Clin Endocrinol Metab 85:35-41, 2000
25. Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Pouviere O, Lang J-M, Gastau J-A, Touraine J-L: A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 13:1659-1667, 1999
26. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman, H, Currier JS, Stone VE, Kaplan JE: Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 39:609-629, 2004